Literature DB >> 8250860

Kinetic mechanism of activation by cardiolipin (diphosphatidylglycerol) of the rat liver multicatalytic proteinase.

I Ruiz de Mena1, E Mahillo, J Arribas, J G Castaño.   

Abstract

The effect of phospholipids on the trypsin-like, chymotrypsin-like and peptidylglutamyl-peptide-hydrolysing activities of the so-called latent form of the rat liver multicatalytic proteinase was studied, assaying them with the following substrates: N-Cbz-ARR-4MNA (N-Cbz, N-benzyloxycarbonyl; 4MNA, 4-methoxy-beta-naphthylamide), N-Suc-LLVY-MCA (N-Suc, N-succinyl; MCA, methylcoumarin) and N-Cbz-LLE-beta-NA (beta-NA, beta-naphthylamide) respectively (amino acids are shown as their one-letter symbol). For the most part neither lysophospholipids nor phospholipids at 20 micrograms/ml have any effect on the activity of the enzyme (assayed at 50 microM peptide), except for phosphatidylserine, which activates 2-fold the hydrolysis of N-Suc-LLVY-MCA, and phosphatidylinositol, which inhibits by 20% the hydrolysis of N-Cbz-LLE-beta-NA. By contrast, cardiolipin (diphosphatidylglycerol) is a strong activator of the hydrolysis of N-Suc-LLVY-MCA (60-fold) and N-Cbz-LLE-beta-NA (30-fold), with half-maximal activation at concentrations of 0.15 micrograms/ml and 1.5 micrograms/ml respectively. The activation of N-Suc-LLVY-MCA hydrolysis is due to an increase of the affinity of the enzyme for the peptide and to an increase in the Vmax. (30-fold). The activation of N-Cbz-LLE-beta-NA hydrolysis is explained by suppressing the co-operativity for this substrate, producing hyperbolic kinetics with a Km of 60 microM and a 15-fold increase in the Vmax. of the enzyme. This activation by cardiolipin was completely suppressed by micromolar concentrations of fluophenazine, a drug known to inhibit other phospholipid-regulated process. Cardiolipin activation and the known activation by SDS are additive, either at suboptimal or optimal concentrations of both activators. Cardiolipin also activates the in vitro degradation of some proteins from metabolically labelled total cellular extracts by the latent multicatalytic proteinase. These results clearly show that cardiolipin is a natural positive modulator of the peptidase and proteolytic activities of the multicatalytic proteinase, probably acting through a binding site different from that of SDS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8250860      PMCID: PMC1137659          DOI: 10.1042/bj2960093

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Protein turnover: proteasome location.

Authors:  A J Rivett; E Knecht
Journal:  Curr Biol       Date:  1993-02       Impact factor: 10.834

2.  The multicatalytic proteinase (prosome) is ubiquitous from eukaryotes to archaebacteria.

Authors:  B Dahlmann; F Kopp; L Kuehn; B Niedel; G Pfeifer; R Hegerl; W Baumeister
Journal:  FEBS Lett       Date:  1989-07-17       Impact factor: 4.124

3.  Identity of the 19S 'prosome' particle with the large multifunctional protease complex of mammalian cells (the proteasome).

Authors:  A P Arrigo; K Tanaka; A L Goldberg; W J Welch
Journal:  Nature       Date:  1988-01-14       Impact factor: 49.962

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  A multicatalytic protease complex from pituitary that forms enkephalin and enkephalin containing peptides.

Authors:  M Orlowski; S Wilk
Journal:  Biochem Biophys Res Commun       Date:  1981-08-14       Impact factor: 3.575

6.  Peptidylglutamyl-peptide hydrolase activity of the multicatalytic proteinase complex: evidence for a new high-affinity site, analysis of cooperative kinetics, and the effect of manganese ions.

Authors:  H Djaballah; A J Rivett
Journal:  Biochemistry       Date:  1992-04-28       Impact factor: 3.162

7.  Role of substrate in reversible activation of proteasomes (multi-protease complexes) by sodium dodecyl sulfate.

Authors:  K Tanaka; T Yoshimura; A Ichihara
Journal:  J Biochem       Date:  1989-09       Impact factor: 3.387

8.  Isolation of two forms of the high-molecular-mass serine protease, ingensin, from porcine skeletal muscle.

Authors:  S Ishiura; M Sano; K Kamakura; H Sugita
Journal:  FEBS Lett       Date:  1985-09-09       Impact factor: 4.124

9.  Activation of the multicatalytic proteinase from rat skeletal muscle by fatty acids or sodium dodecyl sulphate.

Authors:  B Dahlmann; M Rutschmann; L Kuehn; H Reinauer
Journal:  Biochem J       Date:  1985-05-15       Impact factor: 3.857

10.  Cardiolipin activation of dnaA protein, the initiation protein of replication in Escherichia coli.

Authors:  K Sekimizu; A Kornberg
Journal:  J Biol Chem       Date:  1988-05-25       Impact factor: 5.157

View more
  9 in total

Review 1.  Proteasome Activation as a New Therapeutic Approach To Target Proteotoxic Disorders.

Authors:  Evert Njomen; Jetze J Tepe
Journal:  J Med Chem       Date:  2019-03-14       Impact factor: 7.446

2.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

3.  Modulators of the activation of the proteasome by PA28 (11S reg).

Authors:  S Wilk; W E Chen; R P Magnusson
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

Review 4.  Proteasome regulators: activators and inhibitors.

Authors:  Li Huang; Chin Ho Chen
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

5.  Infection with Salmonella typhimurium has no effect on the composition and cleavage specificity of the 20S proteasome in human lymphoid cells.

Authors:  Miguel Marcilla; José Antonio López de Castro; José G Castaño; Iñaki Alvarez
Journal:  Immunology       Date:  2007-05-09       Impact factor: 7.397

Review 6.  Aim for the core: suitability of the ubiquitin-independent 20S proteasome as a drug target in neurodegeneration.

Authors:  Kwadwo A Opoku-Nsiah; Jason E Gestwicki
Journal:  Transl Res       Date:  2018-06-19       Impact factor: 7.012

7.  Structure-based modeling and dynamics of MurM, a Streptococcus pneumoniae penicillin resistance determinant present at the cytoplasmic membrane.

Authors:  Anna York; Adrian J Lloyd; Charo I Del Genio; Jonathan Shearer; Karen J Hinxman; Konstantin Fritz; Vilmos Fulop; Christopher G Dowson; Syma Khalid; David I Roper
Journal:  Structure       Date:  2021-03-18       Impact factor: 5.006

Review 8.  Neuronal death in Alzheimer's disease and therapeutic opportunities.

Authors:  Rossen Donev; Martin Kolev; Bruno Millet; Johannes Thome
Journal:  J Cell Mol Med       Date:  2009-09-01       Impact factor: 5.310

Review 9.  Advances in Proteasome Enhancement by Small Molecules.

Authors:  Dare E George; Jetze J Tepe
Journal:  Biomolecules       Date:  2021-11-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.